UNSPSC 51171655: Sodium picosulfate

This classification denotes a laxative with the molecular formula C18H13NO8S2.2Na, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier LR57574HN8, chemically known as 4,4-(2-pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) disodium salt but more generally known as picosulfate sodium, which bears U.S. NIH Compound Identifier 68654. European Medicines Agency schedules Picosulfate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10569MIG.

The term PICOSULFATE SODIUM is an International Non-Proprietary Name. World Health Organization schedules picosulfate sodium in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51171655 Sodium picosulfate is a Commodity code that in state and local procurement actually covers offender drug testing services, including specimen collection, immunoassay screening, confirmatory testing via LC/MS/MS or GC/MS, and ancillary methodologies such as oral fluid and hair testing. The code sees activity from county community supervision and corrections departments procuring testing services for monitored offenders under probation or parole. The scope encompasses staffing of collection sites, operation of randomized testing notification systems, electronic result reporting, and lab certification compliance with SAMHSA, state DPS, or CAP standards. Vendors must submit pricing on a per-test basis and cover all staffing, freight, delivery, and insurance costs with no additional surcharges permitted.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, for offender specimen collection and drug testing services, with proposals due July 23, 2026 at 2:00 p.m. The county anticipated award August 10, 2026, for a two-year contract term commencing September 1, 2026, with three optional one-year renewal periods not to exceed five years total. The estimated contract value is $600,000, with annual testing demand of approximately 25,031 tests comprising five-panel and six-panel immunoassay screens and confirmatory testing. The county may award in whole or in part to multiple vendors. Evaluation criteria weight vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 additional points. Price redetermination is limited to September 1 anniversaries based on medical Consumer Price Index increases not exceeding 3.0 percent annually, and vendors must honor lower rates offered to other customers.